Vita Life Sciences Delivers Record First Half on Improved Product Mix and Margin Increase
· smallcaps.com.au
Vita Life Sciences hits record H1: revenue $48.3m, NPAT $5.5m, margin up to 63.5%; declares 5.0c dividend; $33.7m cash, no borrowings amid China headwinds.
Vita Life Sciences (ASX: VLS) delivered a record first-half result for the six months to 30 June 2026, with revenue rising 6.1% to $48.3 million and net profit ...